Clinical Trial Update: Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of recombinant human B-type natriuretic peptide (rhBNP) on myocardial remodeling and reperfusion in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• rhBNP (recombinant human B-type natriuretic peptide)

Snippet

Sponsor: RenJi Hospital | Conditions: ST Segment Elevated Myocardial Infarction | Phase 4 | Status: UNKNOWN